Top left panel. The quantitative viral outgrowth assay (QVOA) provided a minimal estimate of the size of the replication-competent reservoir virus from total resting CD4+ T cells of PLWH on ART (n = …
The phylogenetic trees display 5’ (A) and 3’ (B) half genome sequences generated by PacBio sequencing of outgrowth virus from the quantitative viral outgrowth assay from n = 22 PLWH on ART. Each …
Phylogenetic trees displaying 3’ half genome sequences of longitudinal outgrowth virus sequences from seven participants (A–G). Each color represents a different time point in which outgrowth virus …
Phylogenetic trees displaying 5’ half genome sequences of longitudinal outgrowth virus sequences from seven participants (A–G). Each color represents a different time point in which outgrowth virus …
Red dots are participants treated during acute HIV infection.
(A) HLA associations in OGVs: The proportion of polymorphisms harboring HLA-adapted (blue bar) and HLA-adapted + possibly HLA-adapted polymorphisms (light purple) in PLWH on ART (Clade B infected …
(A) The % magnitude of each mapped T cell response (n = 25 participants, n = 166 epitopes) was calculated as a percentage of the total response measured by ELISpot in that individual, and graphed by …
Phylogenetic trees displaying longitudinal outgrowth virus sequences (red text) and DNA sequences, intact (blue text, DNA no stop codon (DNA no_sc)) and non-intact (black text, DNA stop codon …
Participant | Sex | Race* | Ethnicity† | Status at diagnosis‡ | Age§ | Years suppressed¶ | Hiv-1 RNA** | Nadir CD4 | Mean IUPM [n]†† | HLA type |
---|---|---|---|---|---|---|---|---|---|---|
00231 | M | C | NH | A | 66 | 9.66 | 1.5E+07 | 277 | 0.839 [1] | A*11:01, A*24:02, B*35:TDS‡‡‡, B*35:02, C*04:01, C*04:01 |
00250 | M | C | NH | A | 48 | 7.44 | 6.8E+05 | 403 | 0.318 [3] | A*01:01, A*31:01, B*27:03, B*44:02, C*02:02, C*06:02 |
00531 | M | C | NH | C | 52 | 14.87 | 3.8E+05 | 81 | 1.372 [5] | A*02:01, A*02:01, B*07:02, B*44:02, C*03:04, C*07:02 |
00546 | M | C | NH | C | 56 | 20.09§§ | N/A | 195 | 0.453 [2] | A*02:01, A*32:01, B*15:01, B*40:01, C*02:02, C*03:04 |
00673 | M | C | NH | C | 49 | 8.05 | 3.2E+05 | 168 | 0.790 [4] | A*24:02, A*30:02, B*15:17, B*18:01, C*05:01, C*07:01 |
00674 | M | C | NH | C | 57 | 6.25 | 6.8E+04 | 338 | 2.064 [5] | A*02:01, A*03:01, B*07:TDVB§§§, B*40:01, C*03:04, C*07:02 |
00720 | M | C | NH | C | 25 | 2.96 | 4.0E+05 | 168 | 0.499 [4] | A*01:01, A*02:01, B*07:02, B*18:01, C*07:02, C*12:03 |
00728 | M | C | NH | C | 30 | 6.00 | 1.8E+04 | 354¶¶ | 0.676 [6] | A*02:01, A*03:01, B*07:02, B*40:02, C*02:02, C*07:02 |
00749 | M | AA | NH | C | 25 | 4.10 | N/A | 402 | 0.365 [2] | A*03:01, A*30:02, B*15:03, B*40:01, C*02:10, C*03:04 |
00773 | M | C | NH | A | 46 | 2.01 | 2.4E+04 | 234 | 0.233 [1] | A*02:01, A*11:01, B*18:01, B*51:01, C*01:02, C*02:02 |
00833 | M | AA | NH | C | 36 | 8.16 | 7.9E+03 | 358*** | 0.048 [1] | A*02:02, A*74:01, B*15:16, B*82:01, C*03:02, C*14:02 |
00834 | M | AA | NH | C | 25 | 2.15 | 2.1E+04 | 365 | 0.479 [1] | A*02:05, A*30:02, B*51:01, B*58:01, C*04:01, C*16:01 |
00848 | F | C | NH | C | 44 | 4.78 | 1.4E+04 | 800 | 0.022 [1] | A*01:01, A*30:02, B*08:01, B*18:01, C*05:01, C*07:01 |
00870 | M | C | NH | C | 54 | 5.28 | 5.3E+04 | 154††† | 1.400 [1] | A*11:01, A*24:02, B*35:01, B*55:01, C*03:03, C*04:01 |
00879 | F | AA | NH | C | 54 | 1.60 | 4.5E+02 | 612 | 0.093 [1] | A*03:01, A*33:01, B*14:02, B*58:02, C*06:02, C*08:02 |
00926 | F | AA | NH | C | 38 | 3.83 | 1.3E+05 | 508 | 0.262 [1] | A*02:02, A*02:05, B*:39:10, B*45:01, C*12:03, C*16:01 |
00929 | F | AA | NH | C | 61 | 1.77 | 1.9E+04 | 528 | 0.268 [1] | A*01:01, A*74:AB****, B*15:MJMN¶¶¶, B*81:AB****, C*02:10, C*18:01 |
00930 | M | C | NH | C | 53 | 2.70 | 6.4E+05 | 174 | 2.084 [1] | A*01:01, A*11:01, B*08:01, B*40:01, C*03:04, C*07:01 |
00937 | F | AA | NH | C | 45 | 5.84 | 8.8E+04 | 260 | 1.276 [2] | A*03:01, A*30:01, B*35:01, B*52:01, C*04:01, C*16:01 |
00941 | F | C | NH | C | 47 | 14.58 | 6.6E+03 | 12 | 1.50E-08‡‡[1] | N/A |
01014 | F | C | H | C | 52 | 19.85 | 1.2E+06 | 16 | 0.338 [1] | A*23:01, A*74:01, B*07:02, B*41:02, C*15:05, C*17:03 |
01086 | F | AA | NH | C | 30 | 5.81 | N/A | 320 | 0.0529 [1] | A*02:05, A*03:01, B*07:06, B*53:01, C*04:01, C*07:02 |
01095 | F | C | NH | C | 54 | 6.56 | 1.1E+05 | 88 | 2.528 [1] | A*03:01, A*31:01, B*40:01, B*44:02, C*03:04, C*05:01 |
10430 | M | C | NH | C | 59 | 9.47 | 8.1E+04 | 78 | 1.367 [5] | A*02:01, A*30:01, B*13:02, B*51:01, C*06:02, C*14:02 |
20296 | M | C | NH | A | 35 | 6.90 | 2.5E+04 | 427 | 1.50E-08‡‡ [1] | A*29:02, A*31:01, B*08:01, B*44:03, C*07:01, C*16:01 |
Mean: | 46 | 7.22 | 8.6E+05 | 293 | 0.775 | |||||
Range: | 25–66 | 1.6–20.10 | 4.5E+02- 1.5E+07 | 12–800 | 1.50E-08–2.528 |
* C: White/Caucasian, AA: Black/African American.
† NH: Non-Hispanic; H: Hispanic.
‡A: Initiation of ART during acute HIV-1 infection, prior to establishment of setpoint viremia; C: Initiating of ART during chronic HIV-1 infection.
¶ Durable suppression defined as time from ≤ 40 copies/ml to date of T cell measurement.
** HIV-1 RNA at start of combination ART.
†† IUPM (infectious units per million). Mean of IUPM measurements over 2 years from date of T cell mapping.
‡‡ Below the limit of detection.
§§00546 on monotherapy from 1985 to 1996, initiated combination ART in 1996. Years suppressed calculated from data of initiation of cART.
¶¶ CD4 count 261 on 8/17/17 (after cell collection date).
***Lowest CD4 value, CD4 nadir before ART initiation is 567.
†††Lowest CD4 value, CD4 nadir before ART initiation is 157.
‡‡‡B*35:01/B*35:42.
§§§ B*07:02/B*07:61/B*07:16.
¶¶¶ B*15:03/B*15:103/B*15:220.
**** B*81:01/B*81:02.
Participant | Summed magnitude (106/PMBC) | Immunodominant T cell response | Total T cell breadth | # of epitopes with escape variant(s) in outgrowth virus | Escape in immunodominant epitope (Y/N) |
---|---|---|---|---|---|
00231 | 2856 | Vif153→170 | 13 | 3 | Y |
00250 | 1531 | Env765→782 | 10 | 4 | Y |
00531 | 390 | Gag357→374 | 1 | 1 | Y |
00546 | 895 | Gag260→277 | 4 | 1 | N |
00673 | 2313 | Nef73→90 | 5 | 3 | N |
00674 | 1394 | Env838→855 | 7 | 3 | Y |
00720 | 1947 | Pol521→538 | 18 | 8 | Y |
00728 | 439 | Gag204→221 | 7 | 0 | N |
00749 | 418 | Pol481→498 | 6 | 3 | N |
00773 | 1174 | Pol273→290 | 3 | 0 | N |
00833 | 333 | Gag164→181 | 4 | 0 | N |
00834 | 725 | Pol273→290 | 4 | 2 | N |
00848 | 276 | Nef89→106 | 3 | 0 | N |
00870 | 363 | Nef65→82 | 6 | 0 | N |
00879 | 500 | Gag292→309 | 5 | 1 | N |
00926 | 234 | Gag180→197 | 7 | 0 | N |
00929 | 798 | Gag180→197 | 7 | 2 | N |
00930 | 2182 | Nef81→98 | 19 | 7 | Y |
00937 | 297 | Pol257→274 | 5 | 3 | N |
00941 | 2216 | Nef81→98 | 11 | N/A* | N/A* |
01014 | 1463 | Nef65→82 | 9 | 4 | N |
01086 | 258 | Gag17→34 | 3 | 1 | Y |
01095 | 2337 | Pol313→330 | 4 | 2 | N |
10430 | 157 | Nef97→114 | 1 | 1 | Y |
20296 | 331 | Gag204→221 | 4 | N/A* | N/A* |
Total | 166 | 49 (32% - 49/151) | |||
Mean: | 1033 | 7 | 2 | ||
Range: | 157–2856 | 1–19 | 0–8 |
*No outgrowth virus sequence data available to test for the presence of an escape variant in the sequenced outgrowth virus.
Size of the replication-competent reservoir in PLWH on ART (n = 25 participants) as measured by infectious units per million (IUPM) up to 2 years prior to T cell mapping date.
The number of near full-length sequences obtained from p24 antigen positive wells generated in quantitative viral outgrowth assays for each participant, and the pairwise diversity of sequences obtained (5’ and 3’ halves).
Percentage of clonal sequences obtained from p24 antigen positive wells generated in quantitative viral outgrowth assays for each participant (5’ and 3’ halves).
Summary of HLA-associated polymorphism by HIV-1 protein.
Summary of reactive T cell epitopes in study participants.
Raw data from studies evaluating viral T cell escape variants in the replication-competent reservoir.
HIV-1-specific T cell measurements and HIV reservoir size.
HIV-1-specific T cell responses do not correlated with the size of the HIV reservoir.
Correlation between T cell breadth and summed magnitude of T cell response to HIV-1 protein in PLWH on ART (n = 25 participants, n = 166 epitopes), and adjusted for escape variants (n = 23 participants, n = 102 epitopes excluding 49 epitopes at which escape was observed), measured by IFN-γ ELISpot and the size of the replication-competent reservoir as measured by infectious units per million (IUPM) using Spearman Rank.
Reactive T cell epitopes in PLWH on ART (n = 23 participants, 151 total mapped epitopes including 49 escape epitopes) are targeted by conserved immunogen vaccines.
Escape in the HIV-1 reservoir is consistently lower in T cell epitopes that fall within conserved immunogen vaccines than mapped epitopes that fall outside of the immunogens.
Comparison of approaches to assess pre-ART escape in the latent HIV-1 reservoir.